Literature DB >> 1656057

Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984.

A Osterlind1, J G Berthelsen, N Abildgaard, S O Hansen, H Hjalgrim, B Johansen, J Munck-Hansen, L H Rasmussen.   

Abstract

The incidence of a second primary testicular germ cell cancer among 2850 (96.6% of eligible) men with a histologically verified first primary germ cell cancer diagnosed in the period 1960-1979 in Denmark was established. Of these 2850 men, 73 (2.6%) developed a contralateral testicular cancer. In five of these patients (0.18%), the tumors were synchronous. The cumulative risk of developing a contralateral cancer 25 years after diagnosis of the first testicular germ cell cancer was 5.2% according to a Kaplan-Meier estimate. It was higher among men with a nonseminoma as the first tumor (8.4%) than among men with a seminoma as the first tumor (3.6%). Of the second tumors, 12% were stage II and 17% were stage III at the time of diagnosis. Based on 24,588 person-years at risk and 68 nonsimultaneously occurring bilateral testicular germ cell cancers, the overall relative risk (RR) of developing a second primary cancer in the contralateral testicle following a first germ cell cancer was found to be 24.8 (95% confidence interval = 19-38). Among men with a nonseminoma, the risk was higher (RR = 27.1) than among men with a seminoma (RR = 22.5). The excess risk was not affected by age at diagnosis, calendar period, or time since diagnosis. Close surveillance by screening for and treatment of carcinoma in situ of the remaining testicle in testicular cancer patients are advised.

Entities:  

Mesh:

Year:  1991        PMID: 1656057     DOI: 10.1093/jnci/83.19.1391

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  23 in total

Review 1.  Clinical epidemiology of testicular germ cell tumors.

Authors:  K-P Dieckmann; U Pichlmeier
Journal:  World J Urol       Date:  2004-03-18       Impact factor: 4.226

2.  The Validity and Reliability of Health Belief Scale for Testicular Cancer Self-Examination.

Authors:  Ilknur Aydin Avci; Busra Altinel
Journal:  Am J Mens Health       Date:  2015-10-18

3.  Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark.

Authors:  H Møller; A Prener; N E Skakkebaek
Journal:  Cancer Causes Control       Date:  1996-03       Impact factor: 2.506

4.  Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.

Authors:  Ryan P Kopp; Michael Chevinsky; Melanie Bernstein; George Bosl; Robert Motzer; Dean Bajorin; Darren Feldman; Brett S Carver; Joel Sheinfeld
Journal:  Urology       Date:  2016-11-02       Impact factor: 2.649

5.  Bilateral testicular germ cell tumours: a single hospital experience.

Authors:  R Morales-Barrera; C Valverde; J Rodón; J Pérez; X Maldonado; C Suárez; E Trilla; J Carles
Journal:  Clin Transl Oncol       Date:  2010-04       Impact factor: 3.405

Review 6.  Bilateral testicular germ cell tumors.

Authors:  Haşmet Sarıcı; Onur Telli; Muzaffer Eroğlu
Journal:  Turk J Urol       Date:  2013-12

7.  The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.

Authors:  Lajos Géczi; Frederic Gomez; Mihály Bak; István Bodrogi
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-14       Impact factor: 4.553

Review 8.  Genetic factors in malignant germ-cell tumors.

Authors:  K Heimdal; S D Fosså
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 9.  Second cancer after treatment of malignant germ-cell tumors.

Authors:  S D Fosså; E H Wanderås; K Heimdal
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

10.  Management of contralateral testicular intraepithelial neoplasia in patients with testicular germ-cell tumor.

Authors:  K P Dieckmann; V Loy
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.